ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$0.67 USD
+0.03 (4.69%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $0.65 -0.02 (-2.99%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
ImmunoPrecise Antibodies Ltd. (IPA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.00 | $9.00 | $3.00 | 837.50% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for ImmunoPrecise Antibodies Ltd. comes to $6.00. The forecasts range from a low of $3.00 to a high of $9.00. The average price target represents an increase of 837.5% from the last closing price of $0.64.
Analyst Price Targets (2 )
Broker Rating
ImmunoPrecise Antibodies Ltd. currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Strong Buy and one is Buy. Strong Buy and Buy each account for 50% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 |
Buy | 1 | 1 | 1 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Moderate Buy |
7/30/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 2 |
Average Target Price | $6.00 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 71 of 253 |
Current Quarter EPS Est: | -0.09 |
IPA FAQs
ImmunoPrecise Antibodies Ltd. (IPA) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for ImmunoPrecise Antibodies Ltd. (IPA) is $6.00. The current on short-term price targets is based on 1 reports.
The forecasts for ImmunoPrecise Antibodies Ltd. (IPA) range from a low of $3 to a high of $9. The average price target represents a increase of $795.52 from the last closing price of $.67.
The current UPSIDE for ImmunoPrecise Antibodies Ltd. (IPA) is 795.52%
Based on short-term price targets offered by two analysts, the average price target for ImmunoPrecise Antibodies Ltd. comes to $6.00. The forecasts range from a low of $3.00 to a high of $9.00. The average price target represents an increase of 837.5% from the last closing price of $0.64.